LRRK2 and Parkinson disease: Constitutive localization to MTs is a phenotype displayed by three of the four common LRRK2 PD mutants (R1441C, Y1699C, and I2020T) while the hyperactive G2019S mutant, like WT LRRK2, remains cytosolic.